FDA approves Winrevair for pulmonary arterial hypertension in adults
The U.S. Food and Drug Administration has approved Winrevair (sotatercept-csrk) as an injectable treatment for pulmonary arterial hypertension (PAH) in adults.
Mar 29, 2024
0
1
The U.S. Food and Drug Administration has approved Winrevair (sotatercept-csrk) as an injectable treatment for pulmonary arterial hypertension (PAH) in adults.
Mar 29, 2024
0
1
Professor Eung Ju Kim of the Cardiovascular Center, Korea University's Guro Hospital, and his research team identified the gender difference of prescription patterns and clinical prognosis in patients with resistant hypertension ...
Oct 30, 2023
0
8
A team of medical researchers and doctors affiliated with multiple institutions in the U.S. has found, via clinical trial, that the aldosterone synthase inhibitor lorundrostat is likely safe to use for reducing blood pressure ...
Dementia is defined as the loss of cognitive functioning—including thinking, remembering, and reasoning—and is very prevalent in Japan. Currently, the treatment satisfaction for dementia is among the lowest and no drug ...
May 29, 2023
0
52
A long-term analysis designed by Christian Gerges and Irene Lang at the Department of Medicine II of the University Hospital Vienna and MedUni Vienna indicates that one third of patients with chronic thromboembolic pulmonary ...
Apr 27, 2023
0
2
Patients with pulmonary arterial hypertension (high blood pressure in the arteries that supply the lungs, also called PAH) had approximately double the reduction in pulmonary vascular resistance (PVR) if they took the PAH ...
Mar 7, 2023
0
1
A device that uses ultrasound to calm overactive nerves in the kidneys may be able to help some people get their blood pressure under control.
Feb 28, 2023
0
270
Researchers have found that the drug rilmenidine can extend lifespan and slow aging.
Jan 23, 2023
0
56
An experimental drug that is already in clinical trials for other diseases could disrupt a positive feedback loop that exacerbates pulmonary arterial hypertension, a dangerous and rapidly fatal condition for which there is ...
A new drug called Baxdrostat has been shown to significantly reduce high blood pressure (hypertension) in patients who may not respond to current treatments for the condition, according to results from a phase II trial led ...
Nov 8, 2022
0
18